Protective effects of montelukast on vancomycin-induced kidney damage
Phase 3
Recruiting
- Conditions
- Acute renal injury.
- Registration Number
- IRCT20220519054919N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
All children receiving vancomycin over two years of age
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Renal injury due to vancomycin. Timepoint: Patients' creatinine is measured every 48 hours. Method of measurement: Measurement of patients' creatinine.
- Secondary Outcome Measures
Name Time Method